The SERENITY Study: Online Mindfulness-Based Cancer Recovery for Patients With Gynecological Cancer

Plain-language summary

This study examined the effects of an online mindfulness-based cancer recovery program in women with breast or gynecological cancer. It enrolled French-speaking women aged 18 and older diagnosed with breast or any gynecological cancer (stages I to IV). This is a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

University Hospital, Geneva

Intervention

Online Mindfulness-Based Cancer Recovery (MBCR)

Start date

12/19/2019

Estimated completion

9/30/2022

Countries

Switzerland

Related genes

Locations

• Geneva, Switzerland
• Lausanne, Switzerland

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* ≥ 18 years
* Being a woman
* Being diagnosed with breast or any gynecological cancer (either ovarian, cervical, vulvar, womb or vaginal cancer), stages I to IV.
* For women with localized cancers: having completed all adjuvant treatments, such as surgery, chemotherapy and/or radiotherapy, at least 3 months previously, with the exception of hormonal, immune and targeted therapy,
* For women with metastatic cancers: having a performance status \< 3, not undergoing IV chemotherapy and having a life expectancy more than 9 months as estimated by their treating oncologist.
* Free from acute infection for 2 weeks before biochemical assessment.
* Speaking and reading French fluently
* Be able to follow the online course via a computer/tablet

Exclusion Criteria:

* Inability to follow the procedures of the study due to:

  * Significant deafness
  * Physical impairment that prevents attending the sessions
  * Mental retardation (ICD-10)
  * Dementia (ICD-10)
  * Depression (ICD-10) \*
  * Spectrum disorder of schizophrenia (ICD-10) \*\*
  * Alcohol or other substance dependence (ICD-10) \*\*
  * Emotionally labile personality disorder that is incompatible with group participation (ICD-10) \*\*
  * A post-traumatic stress disorder (PTSD) (ICD-10)\*\*
* Currently engages in meditation one or more times per week
* Previous participation in an MBI program
* Serious physiological illnesses that would interfere with the interpretation of biochemical data (e.g., anemia, diabetes, cardiovascular diseases, blood cancers, inflammatory bowel diseases, autoimmune diseases, asthma being treated with steroids, immunodeficiency)